Cedience
Business Intelligence (BI) Software · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
240 Richmond St W, Toronto, Ontario, M5V...Phone Number
(888) 670-6665Website
www.cedience.comRevenue
<$5 MillionIndustry
About Cedience
Cedience Home offers an advanced platform designed to enhance regulatory intelligence by leveraging historical regulatory data to provide evidence-backed insights for complex questions. Their services include reconstructing development timelines, learning from past drug development strategies, and filling intelligence gaps in regulatory approvals. The platform is tailored for regulatory intelligence teams, enabling them to conduct comprehensive research, monitor key topics, and collaborate effectively on projects. Cedience aims to streamline the regulatory research process, making it easier for clients to stay informed and make data-driven decisions.Explore more
Cedience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cedience
Compare insights from companies similar to Cedience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cedience Tech Stack
A closer look at the technologies used by Cedience
See more technologies
Top Business Intelligence (BI) Software Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cedience
Sign Up For FreeTo access detailed company insights
Cedience Home offers an advanced platform designed to enhance regulatory intelligence by leveraging historical regulatory data to provide evidence-backed insights for complex questions. Their services include reconstructing development timelines, learning from past drug development strategies, and filling intelligence gaps in regulatory approvals.... Read More
